Mechanisms of motor complications in treatment of Parkinson's disease.
Kumar
Ajit
A
Pacific Parkinson's Research Centre, Vancouver Hospital and Health Centre, University of British Columbia, Vancouver, British Columbia, Canada.
Huang
Zhigao
Z
de la Fuente-Fernández
Raúl
R
D000818:Animals; D000978:Antiparkinson Agents / Q000009:adverse effects*; D001921:Brain / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D004298:Dopamine / Q000378:metabolism; D004351:Drug Resistance / Q000502:physiology; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology*; D006801:Humans; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D017729:Presynaptic Terminals / Q000187:drug effects / Q000378:metabolism; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000378:metabolism
D000978:Antiparkinson Agents; D017981:Receptors, Neurotransmitter; D004298:Dopamine